S6 Ep21: Biosimilar Oncology Roundup for November 2023—Podcast Edition

Not So Different: A Podcast from The Center for Biosimilars

Show notes

1. Webinar: Where Do Biosimilars Fit Into the Cancer Treatment Puzzle?
2. Part 1: Oncology Biosimilars Offer Comparable Benefits to Originators at Lower Prices
3. Part 2: French Study Finds Trastuzumab Biosimilar Program Could Generate Meaningful Savings
4. Part 3: Study Questions Usefulness of Clinical Efficacy Trials for Oncology Biosimilars in Europe
5. Denosumab Biosimilar Demonstrates Positive Safety Results in Chinese Study
6. Eye on Pharma: Denosumab Biosimilar Data; COA Forms New Committee; IGBA and WHO Collaborate
7. Similar Safety Profiles of Biosimilar, Reference Pegfilgrastim Found in Clinical Studies
8. Study: Biosimilar Use, Dose Rounding Produce More Cost Savings Than Either Strategy Alone